Ensign Peak Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Hold |
28,464
| – | – | ﹤0.01% | 1065 |
|
|
2025
Q1 | $969K | Hold |
28,464
| – | – | ﹤0.01% | 1266 |
|
|
2024
Q4 | $1.12M | Hold |
28,464
| – | – | ﹤0.01% | 1252 |
|
|
2024
Q3 | $1.34M | Hold |
28,464
| – | – | ﹤0.01% | 1150 |
|
|
2024
Q2 | $1.54M | Hold |
28,464
| – | – | ﹤0.01% | 1025 |
|
|
2024
Q1 | $1.94M | Sell |
28,464
-1,436
| -5% | -$97.9K | ﹤0.01% | 943 |
|
|
2023
Q4 | $1.87M | Hold |
29,900
| – | – | ﹤0.01% | 944 |
|
|
2023
Q3 | $1.36M | Hold |
29,900
| – | – | ﹤0.01% | 990 |
|
|
2023
Q2 | $1.68M | Buy |
29,900
+2,200
| +8% | +$124K | ﹤0.01% | 945 |
|
|
2023
Q1 | $1.25M | Buy |
+27,700
| New | +$1.25M | ﹤0.01% | 1069 |
|
|
2022
Q3 | – | Sell |
-37,169
| Closed | -$2.26M | – | 2315 |
|
|
2022
Q2 | $2.26M | Buy |
+37,169
| New | +$2.26M | 0.01% | 758 |
|